The non-benzodiazepine anxiolytic etifoxine limits the sensory-affective expression of pain following streptozotocin-induced diabetic neuropathy
Géraldine Gazzo, Marlene Salgado Ferrer, Pierrick Poisbeau
This study evaluates the analgesic and neuroprotective effects of etifoxine in a mouse model of diabetic neuropathy, showing reduced mechanical hyperalgesia and anxiety.
PLoS ONE · Aug 5, 2021Peer-reviewedNeuroscience